// App-Quantinova.ai

: A Comprehensive Cancer Center Experience with Hyper-CVAD Plus Ponatinib As Frontline Therapy for Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Tamer Othman

Principal Investigators

  • Benjamin Moskoff

  • Matthew Tenold

  • Tali Azenkot

  • Margaret Krackeler

  • Samantha C Fisch

  • Laura A. Potter

  • Paul R. Kaesberg

  • Jeanna Welborn

  • Ted Wun

  • Naseem Esteghamat

  • Rasmus T. Hoeg

  • Aaron S. Rosenberg

  • Mehrdad Abedi

  • Joseph Tuscano

  • Brian A. Jonas

Medical Centers

  • Department of Internal Medicine, University of California Davis School of Medicine, Sacramento

  • Pharmacy Department, University of California Davis School of Medicine, Sacramento, CA

  • University of California Davis Comprehensive Cancer Center, Sacramento, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Hematocrit

Drug/Treatment

  • Ponatinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved